12.00
+1.14(+10.50%)
Currency In USD
Previous Close | 10.86 |
Open | 11 |
Day High | 12.18 |
Day Low | 10.67 |
52-Week High | 30.6 |
52-Week Low | 6.53 |
Volume | 106,022 |
Average Volume | 130,138.1 |
Market Cap | 104.79M |
PE | -1.51 |
EPS | -7.95 |
Moving Average 50 Days | 8.24 |
Moving Average 200 Days | 13.96 |
Change | 1.14 |
If you invested $1000 in Seres Therapeutics, Inc. (MCRB) 10 years ago, it would be worth $299.18 as of July 04, 2025 at a share price of $12. Whereas If you bought $1000 worth of Seres Therapeutics, Inc. (MCRB) shares 5 years ago, it would be worth $2,357.56 as of July 04, 2025 at a share price of $12.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting
GlobeNewswire Inc.
May 27, 2025 11:00 AM GMT
Results highlight potential role of SER-155 in promoting peripheral T-cell recovery and immune reconstitution to support favorable outcomes post allogeneic hematopoietic stem cell transplant (allo-HSCT)CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE
Seres Therapeutics Presents Data at the 2025 Digestive Disease Week Conference Highlighting the Potential for Live Biotherapeutics to Treat Inflammatory and Immune Diseases
GlobeNewswire Inc.
Apr 29, 2025 11:00 AM GMT
CAMBRIDGE, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that it will present three related posters at the upcoming 2025 Digestive Disease Week (DDW) Confe
Seres Therapeutics to Announce First Quarter 2025 Financial Results and Business Updates on May 7, 2025
GlobeNewswire Inc.
Apr 23, 2025 11:00 AM GMT
CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will host a conference call and live audio webcast on May 7, 2025 at 8:30 a.m. ET